Skip to main content
SpringerLink
Log in

Cognitive-Behavioral Therapy for Irritable Bowel Syndrome

  • Chapter
  • First Online:
Using Central Neuromodulators and Psychological Therapies to Manage Patients with Disorders of Gut-Brain Interaction

Abstract

Irritable bowel syndrome (IBS) involves not only abdominal pain and altered bowel habits but also urgency, fear of fecal incontinence, fear of food, and substantial avoidance behavior that can meet criteria for agoraphobia. IBS patients are at increased risk for comorbid psychiatric disorders, especially anxiety and depression. Traditional medical management is often unsatisfactory and does not address comorbidities. Fortunately, cognitive-behavioral therapy is an empirically supported treatment for IBS that addresses comorbidity and IBS symptom severity, and substantially improves quality of life. This chapter illustrates the CBT approach to IBS, explains the rationale behind the treatment and reviews evidence of efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chang L, Toner BB, Fukudo S, et al. Gender, age, society, culture, and the patient’s perspective in the functional gastrointestinal disorders. Gastroenterology. 2006; https://doi.org/10.1053/j.gastro.2005.09.071.

    Article  PubMed  Google Scholar 

  2. Kinsinger SW. Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights. Psychol Res Behav Manag. 2017; https://doi.org/10.2147/PRBM.S120817.

    Article  Google Scholar 

  3. Laird KT, Tanner-Smith EE, Russell AC, Hollon SD, Walker LS. Short-term and long-term efficacy of psychological therapies for irritable bowel syndrome: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016; https://doi.org/10.1016/j.cgh.2015.11.020.

    Article  PubMed  Google Scholar 

  4. Stanculete MF, Dumitrascu DL. Psychiatric comorbidities in IBS patients. J Psychosom Res. 2016; https://doi.org/10.1016/j.jpsychores.2016.03.201.

    Article  Google Scholar 

  5. Lydiard RB. Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psychiatry. 2001;62(Suppl 8):38–45; discussion 46-7. http://www.ncbi.nlm.nih.gov/pubmed/12108820. Accessed 28 Aug 2016.

    Google Scholar 

  6. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016; https://doi.org/10.1053/j.gastro.2016.02.032.

    Google Scholar 

  7. Palsson OS, Whitehead WE. Psychological treatments in functional gastrointestinal disorders: a primer for the gastroenterologist. Clin Gastroenterol Hepatol. 2013; https://doi.org/10.1016/j.cgh.2012.10.031.

    Article  PubMed  Google Scholar 

  8. Grundmann O, Yoon SL. Complementary and alternative medicines in irritable bowel syndrome: an integrative view. World J Gastroenterol. 2014; https://doi.org/10.3748/wjg.v20.i2.346.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Halpert A, Dalton CB, Palsson O, et al. What patients know about Irritable Bowel Syndrome (IBS) and what they would like to know. National survey on patient educational needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am J Gastroenterol. 2007; https://doi.org/10.1111/j.1572-0241.2007.01254.x.

    Article  PubMed  Google Scholar 

  10. Camilleri M, Coulie B, Tack JF. Visceral hypersensitivity: facts, speculations, and challenges. Gut. 2001; https://doi.org/10.1136/gut.48.1.125.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Wilder-Smith CH, Robert-Yap J. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome. World J Gastroenterol. 2007; https://doi.org/10.3748/wjg.v13.i27.3699.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Simrén M, Törnblom H, Palsson OS, et al. Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts. Gut. 2017;

    Google Scholar 

  13. Asano T& TM. Chlorpromazine hydrochloride suppresses visceral hypersensitivity to colorectal distension in a rat model of irritable bowel syndrome. FASEB J. 2017;31(S1)

    Google Scholar 

  14. Wouters MM, Balemans D, Van Wanrooy S, et al. Histamine receptor H1-mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome. Gastroenterology. 2016; https://doi.org/10.1053/j.gastro.2015.12.034.

    Article  Google Scholar 

  15. Labus JS, Bolus R, Chang L, et al. The visceral sensitivity index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther. 2004; https://doi.org/10.1111/j.1365-2036.2004.02007.x.

    Article  CAS  PubMed  Google Scholar 

  16. Labus JS, Mayer EA, Chang L, Bolus R, Naliboff BD. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. Psychosom Med. 2007; https://doi.org/10.1097/PSY.0b013e31802e2f24.

    Article  PubMed  Google Scholar 

  17. Bhatia V, Tandon RK. Stress and the gastrointestinal tract. J Gastroenterol Hepatol. 2005; https://doi.org/10.1111/j.1440-1746.2004.03508.x.

    Article  PubMed  Google Scholar 

  18. Blanchard EB, Lackner JM, Jaccard J, et al. The role of stress in symptom exacerbation among IBS patients. J Psychosom Res. 2008; https://doi.org/10.1016/j.jpsychores.2007.10.010.

    Article  PubMed  Google Scholar 

  19. Moloney RD, O’Leary OF, Felice D, Bettler B, Dinan TG, Cryan JF. Early-life stress induces visceral hypersensitivity in mice. Neurosci Lett. 2012; https://doi.org/10.1016/j.neulet.2012.01.066.

    Article  CAS  PubMed  Google Scholar 

  20. Kennedy PJ, Cryan JF, Quigley EMM, Dinan TG, Clarke G. A sustained Hypothalamic-Pituitary-Adrenal axis response to acute psychosocial stress in irritable bowel syndrome. Psychol Med. 2014; https://doi.org/10.1017/S003329171400052X.

    Article  CAS  PubMed  Google Scholar 

  21. Edman JS, Greeson JM, Roberts RS, et al. Perceived stress in patients with common gastrointestinal disorders: associations with quality of life, symptoms and disease management. Explore (NY). 2017; https://doi.org/10.1016/j.explore.2016.12.005.

    Article  PubMed  Google Scholar 

  22. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. VISCERAL PERCEPTION A role for inflammation in irritable bowel syndrome ? Gut. 2002;

    Google Scholar 

  23. Fukudo S. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007; https://doi.org/10.1007/s00535-006-1942-7.

    Article  CAS  PubMed  Google Scholar 

  24. Collins SM. Modulation of intestinal inflammation by stress: basic mechanisms and clinical relevance. Am J Physiol Gastrointest Liver Physiol. 2001;280(3):G315–8.

    Article  CAS  PubMed  Google Scholar 

  25. Simrén M, Öhman L. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010; https://doi.org/10.1038/nrgastro.2010.4.

    Article  Google Scholar 

  26. Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 2014; https://doi.org/10.1038/nrgastro.2014.40.

    Article  CAS  Google Scholar 

  27. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012; https://doi.org/10.1038/nrn3346.

    Article  CAS  PubMed  Google Scholar 

  28. Dinan TG, Cryan JF. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil. 2013; https://doi.org/10.1111/nmo.12198.

    Article  CAS  Google Scholar 

  29. Moloney RD, Johnson AC, O’Mahony SM, Dinan TG, Greenwood-Van Meerveld B, Cryan JF. Stress and the microbiota-gut-brain axis in Visceral Pain: Relevance to irritable bowel syndrome. CNS Neurosci Ther. 2016; https://doi.org/10.1111/cns.12490.

    Article  Google Scholar 

  30. Kurajian L& GA. In adults with irritable bowle syndrome(IBS) do probiotics improve gastrointestinal symptoms ? Evid Based Pract. 2017;20(6):E7–8.

    Google Scholar 

  31. Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J Gastroenterol. 2015; https://doi.org/10.3748/wjg.v21.i10.3072.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Hunt MG, Milonova M, Moshier S. Catastrophizing the consequences of gastrointestinal symptoms in irritable bowel syndrome. J Cogn Psychother. 2009; https://doi.org/10.1891/0889-8391.23.2.160.

    Article  Google Scholar 

  33. Lackner JM, Quigley BM, Blanchard EB. Depression and abdominal pain in IBS patients: the mediating role of catastrophizing. Psychosom Med. 2004; https://doi.org/10.1097/01.psy.0000126195.82317.46.

    PubMed  Google Scholar 

  34. Hunt MG, Ertel E, Coello JA, Rodriguez L. Development and validation of the GI-cognitions questionnaire. Cogn Ther Res. 2014; https://doi.org/10.1007/s10608-014-9607-y.

    Article  Google Scholar 

  35. Simrén M, Palsson OS, Heymen S, Bajor A, Törnblom H, Whitehead WE. Fecal incontinence in irritable bowel syndrome: prevalence and associated factors in Swedish and American patients. Neurogastroenterol Motil. 2017; https://doi.org/10.1111/nmo.12919.

    Article  Google Scholar 

  36. Hunt MG, Wong C, Aajmain S, Dawodu I. Fecal incontinence in people with self-reported irritable bowel syndrome: prevalence and quality of life. J Psychosom Res. 2018; https://doi.org/10.1016/j.jpsychores.2018.07.015.

    Article  PubMed  Google Scholar 

  37. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.

    Google Scholar 

  38. Gros DF, Antony MM, McCabe RE, Swinson RP. Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression. J Anxiety Disord. 2009; https://doi.org/10.1016/j.janxdis.2008.08.004.

    Article  PubMed  Google Scholar 

  39. Sugaya N, Yoshida E, Yasuda S, et al. Irritable bowel syndrome, its cognition, anxiety sensitivity, and anticipatory anxiety in panic disorder patients. Psychiatry Clin Neurosci. 2013; https://doi.org/10.1111/pcn.12069.

    Article  PubMed  Google Scholar 

  40. Sugaya N, Kaiya H, Kumano H, Nomura S. Relationship between subtypes of irritable bowel syndrome and severity of symptoms associated with panic disorder. Scand J Gastroenterol. 2008; https://doi.org/10.1080/00365520701883478.

    Article  PubMed  Google Scholar 

  41. Bevan JL. Interpersonal communication apprehension, topic avoidance, and the experience of irritable bowel syndrome. Pers Relat. 2009; https://doi.org/10.1111/j.1475-6811.2009.01216.x.

    Article  Google Scholar 

  42. Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome - Etiology, prevalence and consequences. Eur J Clin Nutr. 2006; https://doi.org/10.1038/sj.ejcn.1602367.

    Article  Google Scholar 

  43. Dainese R, Galliani EA, De Lazzari F, Di Leo V, Naccarato R. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol. 1999; https://doi.org/10.1111/j.1572-0241.1999.01226.x.

    Article  CAS  PubMed  Google Scholar 

  44. Hunt M, Zickgraf H, Gibbons B, Loftus P. Development and validation of the Fear of Food Questionnaire (FFQ). In: Annual meeting of the Anxiety and Depression Association of America; 2018.

    Google Scholar 

  45. Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013; https://doi.org/10.1038/ajg.2013.105.

    Article  PubMed  Google Scholar 

  46. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol. 2010; https://doi.org/10.1111/j.1440-1746.2009.06149.x.

    Article  PubMed  Google Scholar 

  47. Shepherd S, Gibson P. The complete low-FODMAP diet book: a revolutionary plan for managing IBS and other digestive disorders. New York: The Experiment Publishing, L.L.C.

    Google Scholar 

  48. Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 2010; https://doi.org/10.1111/j.1440-1746.2010.06370.x.

    Article  CAS  PubMed  Google Scholar 

  49. Staudacher HM, Irving PM, Lomer MCE, Whelan K. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat Rev Gastroenterol Hepatol. 2014; https://doi.org/10.1038/nrgastro.2013.259.

    Article  CAS  Google Scholar 

  50. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014; https://doi.org/10.1053/j.gastro.2013.09.046.

    Article  PubMed  Google Scholar 

  51. Rao SSC, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther. 2015; https://doi.org/10.1111/apt.13167.

    Article  CAS  Google Scholar 

  52. Maagaard L, Ankersen DV, Vegh Z, et al. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol. 2016; https://doi.org/10.3748/wjg.v22.i15.4009.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Anderson JL, Lomer MCE, Staudacher HM, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012; https://doi.org/10.3945/jn.112.159285.

    Article  CAS  PubMed  Google Scholar 

  54. Nanayakkara WS, Skidmore PM, O’Brien L, Wilkinson TJ, Gearry RB. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 2016; https://doi.org/10.2147/CEG.S86798.

  55. Pedersen N, Andersen NN, Végh Z, et al. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol. 2014; https://doi.org/10.3748/wjg.v20.i43.16215.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Böhn L, Störsrud S, Liljebo T, et al. Diet Low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015; https://doi.org/10.1053/j.gastro.2015.07.054.

    Article  PubMed  Google Scholar 

  57. Chawla N, Ostafin B. Experiential avoidance as a functional dimensional approach to psychopathology: an empirical review. J Clin Psychol. 2007; https://doi.org/10.1002/jclp.20400.

    Article  PubMed  Google Scholar 

  58. Ballou S, Keefer L. Psychological interventions for irritable bowel syndrome and inflammatory bowel diseases. Clin Transl Gastroenterol. 2017; https://doi.org/10.1038/ctg.2016.69.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet. 1984; https://doi.org/10.1016/S0140-6736(84)92793-4.

    Article  Google Scholar 

  60. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut. 1987; https://doi.org/10.1136/gut.28.4.423.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Tan G, Hammond DC, Gurrala J. Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action. Am J Clin Hypn. 2005; https://doi.org/10.1080/00029157.2005.10401481.

    Article  PubMed  Google Scholar 

  62. Lindfors P, Unge P, Nyhlin H, et al. Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome. Scand J Gastroenterol. 2012; https://doi.org/10.3109/00365521.2012.658858.

    Article  PubMed  Google Scholar 

  63. Palsson OS. Hypnosis treatment of gastrointestinal disorders: a comprehensive review of the empirical evidence. Am J Clin Hypn. 2015; https://doi.org/10.1080/00029157.2015.1039114.

    Article  PubMed  Google Scholar 

  64. Watanabe S, Hattori T, Kanazawa M, Kano M, Fukudo S. Role of histaminergic neurons in hypnotic modulation of brain processing of visceral perception. Neurogastroenterol Motil. 2007; https://doi.org/10.1111/j.1365-2982.2007.00959.x.

    Article  CAS  Google Scholar 

  65. Whorwell PJ, Houghton LA, Taylor EE, Maxton DG. Physiological effects of emotion: assessment via hypnosis. Lancet. 1992; https://doi.org/10.1016/0140-6736(92)90394-I.

    Article  CAS  Google Scholar 

  66. Lea R, Houghton LA, Calvert EL, et al. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2003; https://doi.org/10.1046/j.1365-2036.2003.01486.x.

    Article  CAS  PubMed  Google Scholar 

  67. Kabat-Zinn J, Lipworth L, Burney R, Sellers W. Four-year follow-up of a meditation-based program for the self-regulation of chronic pain: treatment outcomes and compliance. Clin J Pain. 2008; https://doi.org/10.1097/00002508-198703010-00010.

    Article  Google Scholar 

  68. Gaylord SA, Palsson OS, Garland EL, et al. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol. 2011; https://doi.org/10.1038/ajg.2011.184.

    Article  PubMed  Google Scholar 

  69. Zernicke KA, Campbell TS, Blustein PK, et al. Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial. Int J Behav Med. 2013; https://doi.org/10.1007/s12529-012-9241-6.

    Article  Google Scholar 

  70. Ljótsson B, Falk L, Vesterlund AW, et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome - a randomized controlled trial. Behav Res Ther. 2010; https://doi.org/10.1016/j.brat.2010.03.003.

    Article  PubMed  Google Scholar 

  71. Ljótsson B, Hedman E, Lindfors P, et al. Long-term follow-up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome. Behav Res Ther. 2011; https://doi.org/10.1016/j.brat.2010.10.006.

    Article  PubMed  Google Scholar 

  72. Craske MG, Wolitzky-Taylor KB, Labus J, et al. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther. 2011; https://doi.org/10.1016/j.brat.2011.04.001.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Moss-Morris R, McAlpine L, Didsbury LP, Spence MJ. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care. Psychol Med. 2010; https://doi.org/10.1017/S0033291709990195.

    Article  PubMed  Google Scholar 

  74. Hunt MG, Moshier S, Milonova M. Brief cognitive-behavioral internet therapy for irritable bowel syndrome. Behav Res Ther. 2009; https://doi.org/10.1016/j.brat.2009.05.002.

    Article  PubMed  Google Scholar 

  75. Wolitzky-Taylor K, Craske MG, Labus JS, Mayer EA, Naliboff BD. Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome. Behav Res Ther. 2012; https://doi.org/10.1016/j.brat.2012.05.010.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Chilcot J, Moss-Morris R. Changes in illness-related cognitions rather than distress mediate improvements in irritable bowel syndrome (IBS) symptoms and disability following a brief cognitive behavioural therapy intervention. Behav Res Ther. 2013; https://doi.org/10.1016/j.brat.2013.07.007.

    Article  PubMed  Google Scholar 

  77. Hunt MG, Ertel E, Coello JA, Rodriguez L. Empirical support for a self-help treatment for IBS. Cogn Ther Res. 2015; https://doi.org/10.1007/s10608-014-9647-3.

    Article  Google Scholar 

  78. Ljótsson B, Hesser H, Andersson E, et al. Provoking symptoms to relieve symptoms: a randomized controlled dismantling study of exposure therapy in irritable bowel syndrome. Behav Res Ther. 2014; https://doi.org/10.1016/j.brat.2014.01.007.

    Article  PubMed  Google Scholar 

  79. Ljótsson B, Hesser H, Andersson E, et al. Mechanisms of change in an exposure-based treatment for irritable bowel syndrome. J Consult Clin Psychol. 2013; https://doi.org/10.1037/a0033439.

    Article  PubMed  Google Scholar 

  80. Keefer L, Palsson OS, Pandolfino JE. Best practice update: incorporating psychogastroenterology into management of digestive disorders. Gastroenterology. 2018; https://doi.org/10.1053/j.gastro.2018.01.045.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Pennsylvania, Department of Psychology, Philadelphia, PA, USA

    Melissa G. Hunt

Authors
  1. Melissa G. Hunt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Melissa G. Hunt .

Editor information

Editors and Affiliations

  1. Pleasant Prairie, WI, USA

    W. Harley Sobin

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hunt, M.G. (2019). Cognitive-Behavioral Therapy for Irritable Bowel Syndrome. In: Sobin, W. (eds) Using Central Neuromodulators and Psychological Therapies to Manage Patients with Disorders of Gut-Brain Interaction. Springer, Cham. https://doi.org/10.1007/978-3-030-18218-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-18218-2_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-18217-5

  • Online ISBN: 978-3-030-18218-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation